Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-026383
Filing Date
2021-10-26
Accepted
2021-10-26 21:48:29
Documents
1
Period of Report
2021-10-22

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 14036
  Complete submission text file 0001493152-21-026383.txt   15504
Mailing Address 300 W. 41ST STREET SUITE 202 MIAMI BEACH FL 33140
Business Address 300 W. 41ST STREET SUITE 202 MIAMI BEACH FL 33140 (305) 204-3338
SAB Biotherapeutics, Inc. (Issuer) CIK: 0001833214 (see all company filings)

EIN.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2100 E 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address
Ullerich Melissa Vera (Reporting) CIK: 0001889813 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39871 | Film No.: 211350474